Literature DB >> 7737496

The role of ciprofloxacin in a patient with delirium due to multiple etiologies.

J Farrington1, A Stoudemire, J Tierney.   

Abstract

A 40-year-old female with a lumbar drain was admitted to the neurosurgery service with a bacterial meningitis. During the course of her treatment with multiple central nervous system (CNS) active medications, the patient became disoriented and agitated with visual hallucinations and generalized myoclonus. A psychiatric consultation was requested. The case is presented and discussed within the context of the importance of understanding etiological mechanisms in treating and reversing delirium. The fluoroquinolone agent ciprofloxacin was considered to be the primary etiology of the patient's delirium. This class of medication as a cause of altered mental status is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737496     DOI: 10.1016/0163-8343(94)00065-l

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  5 in total

Review 1.  Quinolones: review of psychiatric and neurological adverse reactions.

Authors:  Ana M Tomé; Augusto Filipe
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

Review 2.  Delirium in the elderly. Optimal management.

Authors:  J M Flacker; E R Marcantonio
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 4.271

3.  Reversible craniocervical dystonia associated with levofloxacin.

Authors:  Karlo J Lizarraga; Maria R Lopez; Carlos Singer
Journal:  J Clin Mov Disord       Date:  2015-05-04

Review 4.  The clinical heterogeneity of drug-induced myoclonus: an illustrated review.

Authors:  Sabine Janssen; Bastiaan R Bloem; Bart P van de Warrenburg
Journal:  J Neurol       Date:  2016-12-16       Impact factor: 4.849

5.  Levofloxacin-induced acute psychosis.

Authors:  Nagaraja Moorthy; N Raghavendra; P N Venkatarathnamma
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.